One world one fight
─Kudyidzana kwenyika dzese kuvaka nharaunda yepasi rose yezvakafanana destiny inopindura COVID-19 denda dambudziko
Iyo novel coronavirus yakatsvaira pasi rose yakonzera dambudziko repasi rose reCOVID-19.Iyo novel coronavirus haina miganhu, hapana nyika ichaponeswa kubva muhondo iyi yekurwisa COVID-19.Mukupindura dambudziko iri repasi rose reCOVID-19, Liming Bio-Products Corp iri kupa zvipo kutsigira kugara zvakanaka kwenharaunda dzedu dzepasi rose.
Nyika yedu parizvino yakatarisana nekukanganisika kusati kwamboitika kweiyo novel coronavirus chirwere 2019 (COVID-19) denda.Kusvika pari zvino, hapana mushonga unoshanda unowanikwa wekurapa chirwere ichi.Nekudaro, akawanda maedzo ekuongorora akagadzirwa kuti aonekwe COVID-19.Iyi bvunzo yakavakirwa pamamorekuru kana serological nzira yekuona iyo novel coronavirus chaiyo nucleic acid kana antibody biomarkers.Sezvo COVID-19 yasvika padanho redenda, kuongororwa kwekutanga kwechirwere chekoronavirus kwakakosha mukuongorora kupararira kwehutachiona uye huinahwo, asi muyedzo wakakwana wekushandiswa kwese hausati wavapo.Isu tinofanirwa kuziva kuti ndedzipi bvunzo dzinogona kushandiswa pakuongorora, kuongororwa, uye kuongorora hutachiona hweCCIDID-19, uye chii chavanogumira.Izvo zvakakosha mashandisiro arinani ezvishandiso zvesainzi uye kubatsira kuona nekudzora kubuda kwechirwere ichi chiri kukurumidza kupararira uye chakakomba.
Chinangwa chekuonekwa kweiyo novel coronavirus ndechekuona kana munhu ane hutachiona hweCCIDID-19 kana kuti asymptotic mutakuri anogona kuparadzira hutachiona chinyararire, kupa ruzivo rwakakosha kutungamira kuita sarudzo pakurapwa kwekiriniki.Zvidzidzo zvakapfuura zvakaratidza kuti 70% yezvisarudzo zvekiriniki zvinoenderana nemhedzisiro yekuedzwa.Kana nzira dzakasiyana dzekuona dzichishandiswa, izvo zvinodikanwa zveagent reagent kits zvakare zvakasiyana.
Mufananidzo 1
Mufananidzo1:Dhiagiramu inoratidza matanho akakosha eakajairwa biomarker mazinga panguva yakajairwa nguva kosi yeCOVID-19 hutachiona.Iyo X-axis inoratidza huwandu hwemazuva ehutachiona, uye Y-axis inoratidza huwandu hwehutachiwana, huwandu hwemaantigen, uye kusangana kwemasoja ekudzivirira panguva dzakasiyana.Antibody inoreva IgM uye IgG masoja ekudzivirira chirwere.Ose ari maviri RT-PCR nekuonekwa kweantigen anoshandiswa kuona kuvepo kana kusavapo kwenovel coronavirus, hunova humbowo hwakananga hwekuonekwa kwemurwere.Mukati mevhiki yehutachiona hwehutachiona, PCR yekuona, kana kuona antigen inosarudzwa.Mushure meiyo novel coronavirus hutachiona kwemazuva manomwe, iyo IgM antibody inopesana neinoveli coronavirus yakawedzera zvishoma nezvishoma muropa remurwere, asi nguva yehupo ipfupi, uye kusungirirwa kwayo kunodzikira nekukurumidza.Kusiyana neizvi, IgG inorwisa hutachiona inoonekwa gare gare, kazhinji mazuva gumi nemana mushure mekutapukirwa nehutachiona.Iyo IgG yakasungwa zvishoma nezvishoma inowedzera, uye inoramba iri nguva yakareba muropa.Saka, kana IgM ikaonekwa muropa remurwere, zvinoreva kuti hutachiona huchangobva kutapukirwa, inova chiratidzo chekutanga chetachiona.Kana IgG antibody ikaonekwa muropa remurwere, zvinoreva kuti hutachiona hwehutachiona hwave kwenguva.Inonzi zvakare hutachiona hwekupedzisira kana hutachiona hwekare.Inowanzoonekwa kune varwere vari muchikamu chekudzorera.
Iyo biomarkers ye novel coronavirus
Iyo novel coronavirus hutachiona hweRNA, hunoumbwa nemapuroteni uye nucleic acids.Hutachiona hunopinda mumunhu (wemunhu) muviri, hunopinda mumaseru kuburikidza neinosunga saiti inoenderana receptor ACE2, uye kudzokorora mumaseru anotambira, zvichiita kuti immune system yemunhu ipindure kune vapambi vekunze uye kugadzira masoja ekudzivirira chirwere.Naizvozvo, iyo vial nucleic acids uye maantigens, uye chaiwo masoja ekudzivirira ekudzivirira ekurwisa coronavirus anogona dzidziso anogona kushandiswa seyakajeka biomarkers yekuona iyo novel coronavirus.Kuti uone nucleic acid, RT-PCR tekinoroji ndiyo inonyanya kushandiswa, nepo nzira dzeserological dzichiwanzo shandiswa pakuona kweinoveli coronavirus-chaiwo masoja ekudzivirira chirwere.Parizvino, pane nzira dzakasiyana dzekuyedza dziripo dzatingasarudza dzekuyedza hutachiona hweCOVID-19 [1].
Nheyo dzekutanga dzemhando huru dzekuedza nzira dzenovel coronavirus
Mazhinji bvunzo dzeCCIDID_19 dziripo kusvika pari zvino, paine mamwe matest kits achiwana mvumo pasi pemvumo yekushandisa yechimbichimbi mazuva ese.Kunyangwe kuvandudzwa kutsva kwebvunzo kunobuda nemazita akawanda akasiyana uye mafomati, ese azvino eCCID_19 bvunzo anonyanya kutsamira pamatekinoroji makuru maviri: nucleic acid yekuona hutachiona RNA uye serological immunoassays inoona hutachiona hwehutachiona (IgM neIgG).
01. Nucleic acid kuonekwa
Reverse transcription-polymerase chain reaction (RT-PCR), loop-mediated isothermal amplification (LAMP), uye inotevera-chizvarwa kutevedzana (NGS) ndiyo yakajairika nucleic acid nzira dzekuonekwa kweinoveli coronavirus RNA.RT-PCR ndiyo yekutanga mhando yebvunzo yeCCIDID-19, yakakurudzirwa neWorld Health Organisation (WHO) neUS Center for Disease Control and Prevention (CDC).
02.Serological antibody kuonekwa
Antibody ipuroteni inodzivirira inogadzirwa mumuviri wemunhu mukupindura kutapukirwa nehutachiona.IgM imhando yekutanga yeantibody nepo IgG iri gare gare mhando yekudzivirira.Iyo serum kana plasma sampuli inowanzoongororwa kuvepo kweiyo IgM uye IgG mhando dzeantibody kuti dziongororwe acute uye convalescent zvikamu zveCOVID-19 hutachiona.Idzi nzira dzekuongorora dzinosanganisira colloidal gold immunochromatography assay, latex kana fluorescent microsphere immunochromatography, enzyme-linked immunosorbent assay (ELISA), uye chemiluminescence assay.
03.Viral antigen kuonekwa
Antigen chimiro pahutachiona chinozivikanwa nemuviri wemunhu chinokonzeresa immune system kuburitsa masoja ekudzivirira chirwere anobvisa hutachiona kubva muropa nematishu.A viral antigen iripo pahutachiona inogona kunangwa uye kuonekwa nekushandisa immunoassay.Kufanana nehutachiona RNA, hutachiona maantigens aripowo mune yekufema turakiti revanhu vane hutachiona uye anogona kushandiswa kuongorora acute-chikamu chehutachiona hweCOVID-19.Naizvozvo, zvinowanzokurudzirwa kuunganidza zvidhori zvekufema zvekumusoro zvakaita semate, nasopharyngeal uye oropharyngeal swabs, chikosoro chakadzika sputum, bronchoalveolar lavage fluid (BALF) yekutanga antigen test.
Kusarudza nzira dzekuyedza dzenovel coronavirus
Kusarudza nzira yekuyedza kunosanganisira zvinhu zvakawanda, zvinosanganisira kurongeka kwekiriniki, kuyedza kudzora mhando, nguva yekuchinja, mutengo wekuyedza, sampling nzira dzekuunganidza, vashandi vemurabhoritari tekinoroji zvinodiwa, nzvimbo nemidziyo zvinodiwa.Kuonekwa kweiyo nucleic acids kana viral antigens ndeyekupa humbowo hwakananga hwekuvapo kwehutachiona uye kusimbisa kuongororwa kweiyo novel coronavirus hutachiona.Kunyangwe paine nzira dzakawanda dzekuona maantigen, kuona kwavo kunzwisiswa kweiyo novel coronavirus kwakadzikira pane iyo yeRT-PCR kukwidziridzwa.Kuongororwa kwemasoja ekudzivirira utachiona ndiko kuona kwemasoja ekudzivirira utachiona anogadzirwa mumuviri wemunhu, ayo ari kunonoka nenguva uye kazhinji haagone kushandiswa mukukasika kuonekwa panguva yakaoma yehutachiona hwehutachiona.Mamiriro ekiriniki ekuonekwa kwezvikumbiro anogona kusiyana, uye nzvimbo dzekuunganidza dzemuenzaniso dzinogonawo kunge dzakasiyana.Kuonekwa kwehutachiwana hwenyucleic acids nemaantigens, mufananidzo wacho unofanirwa kuunganidzwa munzira yekufema uko hutachiona hunenge huripo, senge nasopharyngeal swabs, oropharyngeal swabs, sputum, kana bronchoalveolar lavage fluid (BALF).Kuti zvionekwe nemasoja ekudzivirira chirwere, sampuli yeropa inoda kuunganidzwa uye kuongororwa kuti pane chaiyo anti-virus antibody (IgM/IgG).Nekudaro, antibody uye nucleic acid mhedzisiro yebvunzo inogona kuenderana.Semuyenzaniso, kana mhedzisiro yekuyedza iri nucleic acid-negative, IgM-negative asi IgG-positive, mhedzisiro iyi inoratidza kuti murwere haatakure hutachiona parizvino, asi akapora kubva kuhutachiona hwekoronavirus.[2]
Zvakanakira uye zvakaipira zve novel coronavirus bvunzo
MuDiagnostics and Treatment Protocol yeNovel Coronavirus Pneumonia (Trial Version7) (Yakaburitswa neNational Health Commission & State Administration of Traditional Chinese Medicine munaKurume 3, 2020), nucleic acid yekuongorora inoshandiswa senzira yegoridhe yakajairwa kuongororwa kwerinovhero. hutachiona hwekoronavirus, nepo kuongororwa kweantibody kunoonekwawo seimwe yenzira dzekusimbisa kuongororwa.
Pathogenic uye serological zvakawanikwa
(1) Pathogenic zvakawanikwa: Novel coronavirus nucleic acid inogona kuwonekwa mu nasopharyngeal swabs, sputum, yakadzika yekufema turakiti secretion, ropa, tsvina uye zvimwe sampuli uchishandisa RT-PCRand/ kana NGS nzira.Izvo zvakanyatsorurama kana zvienzaniso zvinowanikwa kubva pasi pekufema turakiti (sputum kana air tract extraction).Mienzaniso inofanira kuendeswa kunoongororwa nokukurumidza sezvinobvira mushure mekuunganidza.
(2) Serological zvakawanikwa: NCP hutachiona hweIgM hunova hunoonekwa mukati memazuva 3-5 mushure mekutanga;IgG inosvika pakuderedzwa kweinenge 4-yakapetwa kuwedzera panguva yekuvandudza kana ichienzaniswa neyakaoma chikamu.
Nekudaro, kusarudzwa kwenzira dzekuyedza kunoenderana nenzvimbo, mirau yekurapa, uye kiriniki marongero.MuUSA, iyo NIH yakapa Coronavirus Chirwere 2019 (COVID-19) Mazano Ekurapa (Siti Yakagadziridzwa: Kubvumbi 21,2020) uye FDA yakapa Polisi yeDiagnostic Tests yeCoronavirus Chirwere-2019 panguva yePublic Health Emergency (yakabudiswa munaKurume 16,2020. ), umo serological yekuongorora yeIgM/IgG masoja ekudzivirira chirwere anosarudzwa chete seyekuongorora.
Nucleic Acid Detection Method
RT_PCR ndeye inonzwisa tsitsi nucleic acid bvunzo yakagadzirirwa kuona kana riini riini coronavirus RNA iripo mukufema kana imwe sampuli.Yakanaka PCR bvunzo mhedzisiro inoreva kuvepo kweinoveli coronavirus RNA mumuenzaniso kuratidza hutachiona hweCOVID-19.Mhedzisiro isina kunaka yePCR bvunzo hairevi kusavapo kwehutachiona hwehutachiona nekuti inogona kukanganiswa nehurombo hwemhando yemhando kana chirwere chenguva pachikamu chakadzoserwa, nezvimwe.Kunyangwe RT-PCR iri bvunzo ine hunyanzvi, ine zvipingamupinyi zvakati wandei.RT-PCR bvunzo dzinogona kushanda-yakawanda uye dzinopedza nguva, zvakanyanya zvinoenderana nemhando yepamusoro yemuenzaniso.Izvi zvinogona kuva dambudziko nekuti huwandu hwehutachiona hweRNA haungosiyana zvakanyanya pakati pevarwere vakasiyana asi zvakare hunogona kusiyanisa mukati memurwere mumwechete zvichienderana nenguva iyo sampu inounganidzwa pamwe nezvikamu zvehutachiona kana kutanga kwezviratidzo zvekiriniki.Kuona iyo novel coronavirus kunoda emhando yepamusoro mienzaniso ine huwandu hwakakwana hwehutachiona hweRNA.
Iyo RT-PCR bvunzo inogona kupa isiriyo yakaipa mhedzisiro (yenhema yakaipa) kune vamwe varwere vane hutachiona hweCOVID-19.Sezvatinoziva, nzvimbo huru dzehutachiona dzeinoveli coronavirus dziri pamapapu uye pazasi pekufema turakiti, senge alveoli uye bronchi.Naizvozvo, sputum yemuenzaniso kubva pachikosoro chakadzika kana bronchoalveolar lavage fluid (BALF) inoonekwa seine kunzwisiswa kwepamusoro pakuona hutachiona.Nekudaro, mukuita kwekiriniki, sampuli dzinowanzo kuunganidzwa kubva kumusoro rekufema turakiti nekushandisa nasopharyngeal kana oropharyngeal swabs.Kutora zvienzaniso izvi hakungofadzi varwere chete asi kunodawo vashandi vakanyatsodzidziswa.Kuita kuti sampling isanyanya kupindira kana nyore, mune dzimwe nguva varwere vanogona kupihwa oral swab uye kuvabvumira kutora sampuli kubva mubuccal mucosa kana rurimi vachizviputira ivo pachavo.Pasina hutachiona hwakakwana RNA, RT-qPCR inogona kudzosera yenhema-negative bvunzo mhinduro.Mupurovhinzi yeHubei, China, RT-PCR senitivity mukuonekwa kwekutanga yakangotaurwa ingangoita 30% -50%, neavhareji ye40%.Nhamba yepamusoro yenhema-negative ingangove yakakonzerwa nekusakwana sampling.
Uye zvakare, iyo RT-PCR bvunzo inoda vashandi vakadzidziswa zvakanyanya kuita yakaoma RNA yekubvisa matanho uye PCR amplification maitiro.Inodawo mwero wepamusoro wekuchengetedza biosafety, yakakosha marabhoritari nzvimbo, uye chaiyo-nguva PCR chiridzwa.KuChina, iyo RT-PCR bvunzo yekuonekwa kweCCIDID-19 inofanirwa kuitwa mubiosafety level 2 marabhoritari (BSL-2), nekuchengetedzwa kwevashandi vachishandisa biosafety level 3 (BSL-3) tsika.Pasi pezvinodiwa izvi, kubva kutanga kwaNdira kusvika kutanga kwaFebruary 2020, kugona kweChina Wuhan's CDC laboratory yakangokwanisa kuona mazana mashoma emhosva pazuva.Kazhinji, izvi hazvingavi dambudziko pakuedza zvimwe zvirwere zvinotapukira.Nekudaro, kana uchibata nedenda repasi rose rakadai seCCIDID-19 ine mamirioni avanhu kuti vaongororwe, RT-PCR inova nyaya yakaoma nekuda kwezvinodiwa zvezvivakwa zvemurabhoritari kana michina yehunyanzvi.Izvi zvinokanganisa zvinogona kudzikisira iyo RT-PCR kuti ishandiswe sechinhu chinoshanda chekuongorora, uye zvakare inogona kutungamira kunonoka mumishumo yemhedzisiro yekuyedzwa.
Serological antibody yekuona nzira
Nekufambira mberi kwechirwere chekosi, kunyanya pakati nepakati nepakati, mwero wekuona masoja ekudzivirira chirwere wakakwira zvakanyanya.Ongororo yakaitwa muWuhan Central South Hospital yakaratidza kuti mwero wekuona antibody unogona kusvika kudarika 90% musvondo rechitatu rehutachiona hweCOVID-19.Zvakare, iyo antibody chigadzirwa chemhinduro yemuviri wemunhu kurwisa iyo novel coronavirus.Iyo antibody bvunzo inopa akati wandei mabhenefiti pamusoro peRT-PCR.Chekutanga, iyo serological antibody inoedza nyore uye nekukurumidza.Antibody lateral kuyerera bvunzo inogona kushandiswa kune point-ye-kutarisira kuunza mhedzisiro mumaminetsi gumi nemashanu.Kechipiri, chinangwa chakaonekwa neiyo serological bvunzo ndeye antibody, inozivikanwa kuve yakagadzikana zvakanyanya kupfuura hutachiona RNA.Munguva yekuunganidza, kutakura, kuchengetedza uye kuyedzwa, zvienzaniso zvebvunzo dzeantibody zvinowanzogadzikana kupfuura zvienzaniso zveRT-PCR.Chetatu, nekuti masoja ekudzivirira chirwere akagovaniswa zvakaenzana mukutenderera kweropa, pane mashoma sampling mutsauko uchienzaniswa neiyo nucleic acid bvunzo.Sample vhoriyamu inodiwa pakuyedza masoja ekudzivirira chirwere idiki.Semuyenzaniso, 10 microliter yemunwe-pick blood inokwana kushandiswa muantibody lateral flow test.
Kazhinji, iyo antibody bvunzo inosarudzwa sechishandiso chekuwedzera chenyucleic acid yekuona kuvandudza mwero wekuonekwa kweiyo novel coronavirus panguva yechirwere makosi.Kana iyo antibody bvunzo ikashandiswa pamwe chete neiyo nucleic acid bvunzo, inogona kuwedzera assay chokwadi chekuongororwa kweCCIDID19 nekudzikisa zvingangoitika zvekunyepa uye zvenhema-zvisina kunaka.Iyo yazvino dhizaini dhizaini haikurudzire kushandisa mhando mbiri dzebvunzo dzakasiyana seyakazvimirira yekuona fomati asi inofanirwa kushandiswa seyakasanganiswa fomati.[2]
Mufananidzo 2:Dudziro chaiyoiyo ye nucleic acid uye antibody bvunzo mhedzisiro yekuonekwa kweiyo novel coronavirus hutachiona
Mufananidzo 3:Liming Bio-Products Co., Ltd. - Novel coronavirus IgM/IgG antibody mbiri yekukurumidza bvunzo Kit (YakasimbaStep®SARS-CoV-2 IgM/IgG Antibody Rapid Test, Latex Immunochromatography)
Mufananidzo 4:Liming Bio-Products Co., Ltd. – StrongStep®Novel Coronavirus (SARS-CoV-2) Multiplex Chaiyo-Nguva PCR kit (yekuona majini matatu, fluorescent probe nzira).
Cherechedza:Iyi PCR kit inonzwisisika zvakanyanya, yakagadzirira kushandisa inowanikwa mu lyophilized fomati (kuomesa-kuomesa) kuchengetedza kwenguva refu.Iyo kiti inogona kutakurwa uye kuchengetwa mukamuri tembiricha uye inogadzikana kwegore rimwe.Imwe neimwe chubhu ye premix ine ese mareagents anodiwa paPCR amplification, kusanganisira Reverse-transcriptase, Taq polymerase, primers, probes, uye dNTPs substrates.Vashandisi vanogona kungogadzirisa musanganiswa nekuwedzera PCR-giredhi mvura pamwe chete netemplate uye vozotakura. paPCR chiridzwa kumhanyisa kukwidziridzwa.
Mukupindura padenda rekoronavirus, Liming Bio-Products Co., Ltd. yakashanda nekukurumidza kugadzira makiti maviri ekuongorora kuti agonese marabhoritari ekiriniki neveruzhinji kuti aone hutachiona hweCOVID-19 nekukurumidza.Aya makiti akanyatsokodzera kushandiswa pakuongorora kukuru munyika nematunhu uko denda idzva re coronavirus riri kupararira nekukurumidza, uye nekupa kuongororwa uye kusimbiswa kwehutachiona hweCOVID-19.Aya makiti ndeekushandisa chete pasi pe Pre-notified Emergency Use Authorization (PEUA).Kuedzwa kunogumira kumarabhoritari akasimbiswa pasi pemitemo yehurumende yenyika kana yenzvimbo.
Antigen yekuona nzira
1. Viral antigen diagnosis inorongedzerwa muchikamu chimwechete chekuona zvakananga se nucleic acid yekuona.Idzi nzira dzekuona dzakananga dzinotsvaga humbowo hwehutachiona hwehutachiona mumuenzaniso uye hunogona kushandiswa sechisimbiso chekuongorora.Zvisinei, kugadzirwa kwemaantigen ekuona kits kunoda hupamhi hwepamusoro hwemonoclonal antibodies ane hukama hwakasimba uye hukuru hwekunzwa hunokwanisa kuziva uye kutora mavhairasi epathogenic.Zvinowanzotora mwedzi inodarika mitanhatu kusarudza nekugadzirisa monoclonal antibody yakakodzera kushandiswa mukugadzirira kwekiti yekuona antigen.
2. Parizvino, ma reagents ekuonekwa kwakananga kweiyo novel coronavirus achiri pasi pekutsvagisa uye danho rekusimudzira.Nokudaro, hapana antigen yekuona kit yakave yakasimbiswa nekliniki uye inotengeswa.Kunyange zvazvo zvakambotaurwa kuti diagnostic femu muShenzhen yakagadzira antigen yekuongorora kit uye yakaedzwa nekliniki muSpain, kuvimbika kwekuongorora uye kurongeka kwaisagona kusimbiswa nekuda kwekuvapo kwehutano hwe reagent.Parizvino, NMPA (yaimbova China FDA) haisati yabvumidza chero antigen kit yekuona kuti ishandiswe mukiriniki.Mukupedzisa, nzira dzakasiyana-siyana dzekuona dzakagadzirwa.Imwe neimwe nzira ine zvayakanakira nezvainogumira.Mhedzisiro kubva kunzira dzakasiyana dzinogona kushandiswa kuonesa uye kuzadzisa.
3. Kugadzira yemhando yeCCIDID-19 test kit zvakanyanya zvinoenderana nekugadzirisa panguva yekutsvaga nekusimudzira.Liming Bio-Product Co., Ltd.test kits inodiwa kuti isangane neyakaomesesa yekugadzira uye yemhando yekudzora zviyero kuti ive nechokwadi chekuti inopa epamusoro mazinga ekuita uye kuenderana.Masayendisiti kuLiming Bio-Chigadzirwa Co., Ltd vane makore anopfuura makumi maviri 'ruzivo mukugadzira, kuyedza, uye optimize in vitro diagnostic kits kuti ive nechokwadi chepamusoro chekuita mu analytical quantification.
Munguva yeCOVID-19 Pandemic, hurumende yeChinese yakatarisana nekuwedzera kwekuda kukuru kwezvinhu zvekudzivirira denda munzvimbo dzepasi rose.Musi waApril 5, pamusangano wevatori venhau we State Council Joint Prevention and Control Mechanism "Kusimbisa Hunhu Hwekutarisira Zvishandiso Zvekurapa uye Kudzora Kurongeka kweMusika", Jiang Fan, muongorori wekutanga weDhipatimendi Rezvekutengeserana kunze kweBazi. weCommerce, akati, "Zvinotevera, tichatarisa kuedza kwedu pazvinhu zviviri, chekutanga, kukurumidza kutsigirwa kwezvimwe zvekurapa zvinodiwa nenharaunda dzepasirese, uyezve, kuvandudza kudzora kwemhando, kudzora, uye manejimendi ezvigadzirwa. Tichaita mupiro weChina mukupindura takabatana denda repasi rose uye kuvaka nharaunda ine ramangwana rakagovaniswa revanhu.
Mufananidzo 5:Liming Bio-Products Co., Ltd.'s novel coronavirus reagent yawana EU CE chitupa chekunyoresa.
The honorary certificate
Houshenshan
Mufananidzo 6. Liming Bio-Products Co., Ltd. yakatsigira Wuhan Vulcan(HouShenShan) Mountain Hospital kurwisa denda reCOVID-19 uye yakapihwa chitupa chekuremekedza cheWuhan Red Cross.Wuhan Vulcan Mountain Hospital ndicho chipatara chine mukurumbira muChina chinorapa varwere vakanyanya COVID-19.
Sezvo denda idzva rekoronavirus richiramba richipararira pasirese, Nanjing Liming Bio-Products Co., Ltd. iri kusimuka kutsigira nekubatsira nharaunda pasi rese nehunyanzvi hwedu hwekurwisa dambudziko iri risati ramboitika pasi rose.Kukurumidza kuyedzwa kwehutachiona hweCCIDID-19 chikamu chakakosha chekugadzirisa kutyisidzira uku.Isu tinoenderera mberi nekubatsira nenzira yakakosha nekupa mapuratifomu epamusoro-soro mumaoko evashandi vehutano vepamberi kuitira kuti vanhu vagamuchire mhinduro dzakakomba dzavanoda.Kuedza kweLiming Bio-products Co., Ltd. muhondo yekurwisa denda reCCIDID-19 ndeyekupa matekinoroji edu, zviitiko, uye hunyanzvi kunharaunda dzepasirese kuvaka nharaunda yepasirese yezvaizoitika.
Dzvanya Yakareba ~ Scan uye Titevere
Email: sales@limingbio.com
Webhusaiti: https://limingbio.com
Nguva yekutumira: May-01-2020
